Osaterone
Osaterone (developmental code name TZP-5258), also known as 17α-hydroxy-6-chloro-2-oxa-6-dehydroprogesterone, as well as 2-oxachloromadinone, is a steroidal antiandrogen and progestin that was never marketed.[1][2] The C17α acetate ester of osaterone, osaterone acetate, in contrast, has been marketed.[1][2]
This article is about a non-clinically used antiandrogen compound. For the pharmaceutical drug, see osaterone acetate.
 | |
| Clinical data | |
|---|---|
| Other names | TZP-5258; Gestoxarone; 2-Oxachloromadinone; 17α-Hydroxy-6-chloro-2-oxa-6-dehydroprogesterone; 17α-Hydroxy-6-chloro-2-oxapregna-4,6-diene-3,20-dione |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H25ClO4 |
| Molar mass | 364.87 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
See also
References
- Index Nominum: International Drug Directory. MedPharm. 2011. ISBN 978-3-8047-5053-1.
- Milne GW (8 May 2018). Drugs: Synonyms and Properties: Synonyms and Properties. Taylor & Francis. pp. 969–. ISBN 978-1-351-78989-9.
| PR |
| ||||||
|---|---|---|---|---|---|---|---|
| mPR (PAQR) |
| ||||||
| |||||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.